Christopher Kroeger

About Christopher Kroeger

Christopher Kroeger is a chief executive officer and director at MapLight Therapeutics.

Christopher Kroeger reports to the SEC as a director or officer of 2 public companies, including Tempest Therapeutics (TPST).

Christopher Kroeger first appears on SEC filings in 2017.

Experience

This experience comes from SEC filings. The years are when the filings name Christopher Kroeger in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Christopher Kroeger works with at each company, as listed on that company's latest Form D.

Sources

1. SECMapLight Therapeutics, Inc. Form D, filed Jul 28, 2025
2. SECForms 3, 4 and 5 filed by Christopher Kroeger (SEC filer 1658918)